“…Assessment of MR images obtained after administration of a paramagnetic contrast agent must be done with caution, because any pathology associated with disruption of bloodbrain barrier (BBB) results in post-contrast enhancement 9 . Advanced MR techniques, like MR spectroscopy and diffusion-weighted imaging, can provide insight in physiological changes within pathology and contribute to more successful distinguishing between tumor types and their separation from tumor mimicking lesions 1,10 .…”